A Phase I, Cross-Over, Single Dose, Double-Blind Study To Estimate The Relative Bioavailability Of Three Different Formulations Of PF-05190457 In Healthy Adult Volunteers
Latest Information Update: 07 Nov 2021
At a glance
- Drugs PF 5190457 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 02 Feb 2012 New trial record